Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Juni 2026 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance

IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
27. Mai 2026 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Appoints Edward Sarnowski as Chief Technology Officer

IRVINE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
20. Mai 2026 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs

IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
12. Mai 2026 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Appoints Dave Haan as Vice President of Clinical Affairs

IRVINE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of...
01. April 2026 08:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)

IRVINE, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the successful first...
18. März 2026 08:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States

IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food...
29. Januar 2026 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Appoints John Molyneux to Vice President of Operations

IRVINE, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the appointment of...
24. November 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves

IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from an...
17. November 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System

IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its...
10. November 2025 09:00 ET | Quelle: JenaValve Technology, Inc.

JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025

IRVINE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the...

Nächste Seite